DUSP14 and metabolic dysfunction-associated steatohepatitis: In the present study, we found that OPG could regulate the activity of the MAPK signaling pathway via DUSP14, thus regulating the expression of some inflammatory factors in NASH, indicating that it may be a promising target for the treatment of NASH.